Global Deoxyribonucleic Acid (DNA) Vaccines Professional Market Insights, Players, Region, Type & Application Analysis 2018-2029

Report ID: ARS11798 | Category: Healthcare | Pages: 122 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$4680.00 Multi User-$7900.00

Report Description
View Table of Contents

Report Summary

The global Deoxyribonucleic Acid (DNA) Vaccines market size in 2022 is 465.6 million US dollars, and it is expected to be 747.7 million US dollars by 2029, with a compound annual growth rate of 7.00% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Deoxyribonucleic Acid (DNA) Vaccines market include F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), and Pfizer Inc. (U.S.). The share of the top 3 players in the Deoxyribonucleic Acid (DNA) Vaccines market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Deoxyribonucleic Acid (DNA) Vaccines market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Genetic Vaccines accounted for XX% of Deoxyribonucleic Acid (DNA) Vaccines market in 2022. Recombinant Protein Vaccines share of XX%.
Human Health accounted for XX% of the Deoxyribonucleic Acid (DNA) Vaccines market in 2022. Animal Health accounts for XX%.

The cumulative impact of COVID-19, Russia-Ukraine conflict, and high inflation is expected to have a significant long-term impact on the global Deoxyribonucleic Acid (DNA) Vaccines markets. Ongoing research considers changes in consumer behavior, supply chain disruptions, and government intervention caused by the pandemic. Likewise, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine conflict and its potential impact on the supply-demand balance, pressure on pricing variables, and import, export, and trade. In addition, the report discusses the impact of high inflation on the global economy and details fiscal policies to measure and reduce its impact on demand, supply, cash flows, and currency exchange.

Market Statistics:
Reports provide market sizes and forecasts for multiple major currencies (USD, EUR, JPY, GBP, CNY, etc.); multi-currency support helps organizational leaders make informed decisions. This report takes 2018-2021 as the historical year, 2022 as the base year, 2023 as the semi-forecast year, and 2024-2029 as the full forecast year.

Market Share Analysis:
Market share analysis provides deep insights into the current status of vendors in a particular market space. By comparing suppliers' contributions to total revenue, customer base, and other key metrics, we can give companies a better understanding of their performance and the challenges they face as they compete for market share. The analysis also sheds light on the competitiveness of any given sector in terms of accumulation, diversification of strengths, and consolidation characteristics during the base year studied.

The report provides insights on the following metrics:
Market Penetration: Provides comprehensive information on the market offered by key players
Market Diversification: Provides detailed information on new product launches, greenfield regions, recent developments and investments
Market Trends: A Big Picture of the Cumulative Impact of COVID-19, Russia-Ukraine Conflict, and High Inflation
Competitive assessment and intelligence: Provides an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape and manufacturing capabilities of leading players
Product Development & Innovation: Provides intelligent insights into future technologies, R&D activities, and breakthrough product developments
Market Segmentation: Segment by Type, Application, and Region to provide detailed insights into market information.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, application, and regional division, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Deoxyribonucleic Acid (DNA) Vaccines market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapter 3: Analyzes the main companies in the Deoxyribonucleic Acid (DNA) Vaccines industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapters 4-6: Segmented the global Deoxyribonucleic Acid (DNA) Vaccines market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-15: Provide North America, Europe, China, Japan, Korea, Southeast Asia, India, South America and Middle East & Africa Deoxyribonucleic Acid (DNA) Vaccines market type, application, PEST analysis and players market segmentation data.
Chapter 16: Analyzes the Deoxyribonucleic Acid (DNA) Vaccines business cost, including industrial chain and the proportion of business cost structure.
Chapter 17: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 18: The main points and conclusions of the report.

Highlights-Regions
North America
Europe
China
Japan
Korea
Southeast Asia
India
South America
Middle East & Africa

Player list
F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Sanofi (France)
Pfizer Inc. (U.S.)
GSK plc (U.K.)
Novartis AG (Switzerland)
Serum Institute of India Pvt. Ltd (India),
Fotona (U.S.)
G.C. Biopharma (South Korea)
Sanofi (France), Zoetis (U.S.).
INOVIO Pharmaceuticals (U.S.).
General Electric (U.S.)
Biomay AG (Austria)
Valneva SE (France)

Types list
Genetic Vaccines
Recombinant Protein Vaccines

Application list
Human Health
Animal Health
Research Application

Table of Content

1 Deoxyribonucleic Acid (DNA) Vaccines Market Introduction and Overview
1.1 Deoxyribonucleic Acid (DNA) Vaccines Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Deoxyribonucleic Acid (DNA) Vaccines Revenue and Market Share by Manufacturer
2.2 Manufacturers Deoxyribonucleic Acid (DNA) Vaccines Production Sites, Area Served, Product Types
2.3 Deoxyribonucleic Acid (DNA) Vaccines Market Competitive Situation and Trends
2.3.1 Deoxyribonucleic Acid (DNA) Vaccines Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 F. Hoffmann-La Roche Ltd. (Switzerland)
3.1.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile
3.1.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.1.3 F. Hoffmann-La Roche Ltd. (Switzerland) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.1.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview
3.2 Mylan N.V. (U.S.)
3.2.1 Mylan N.V. (U.S.) Company Profile
3.2.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.2.3 Mylan N.V. (U.S.) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.2.4 Mylan N.V. (U.S.) Business Overview
3.3 Teva Pharmaceutical Industries Ltd. (Israel)
3.3.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Profile
3.3.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.3.3 Teva Pharmaceutical Industries Ltd. (Israel) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.3.4 Teva Pharmaceutical Industries Ltd. (Israel) Business Overview
3.4 Sanofi (France)
3.4.1 Sanofi (France) Company Profile
3.4.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.4.3 Sanofi (France) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.4.4 Sanofi (France) Business Overview
3.5 Pfizer Inc. (U.S.)
3.5.1 Pfizer Inc. (U.S.) Company Profile
3.5.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.5.3 Pfizer Inc. (U.S.) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.5.4 Pfizer Inc. (U.S.) Business Overview
3.6 GSK plc (U.K.)
3.6.1 GSK plc (U.K.) Company Profile
3.6.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.6.3 GSK plc (U.K.) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.6.4 GSK plc (U.K.) Business Overview
3.7 Novartis AG (Switzerland)
3.7.1 Novartis AG (Switzerland) Company Profile
3.7.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.7.3 Novartis AG (Switzerland) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.7.4 Novartis AG (Switzerland) Business Overview
3.8 Serum Institute of India Pvt. Ltd (India),
3.8.1 Serum Institute of India Pvt. Ltd (India), Company Profile
3.8.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.8.3 Serum Institute of India Pvt. Ltd (India), Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.8.4 Serum Institute of India Pvt. Ltd (India), Business Overview
3.9 Fotona (U.S.)
3.9.1 Fotona (U.S.) Company Profile
3.9.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.9.3 Fotona (U.S.) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.9.4 Fotona (U.S.) Business Overview
3.10 G.C. Biopharma (South Korea)
3.10.1 G.C. Biopharma (South Korea) Company Profile
3.10.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.10.3 G.C. Biopharma (South Korea) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.10.4 G.C. Biopharma (South Korea) Business Overview
3.11 Sanofi (France), Zoetis (U.S.).
3.11.1 Sanofi (France), Zoetis (U.S.). Company Profile
3.11.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.11.3 Sanofi (France), Zoetis (U.S.). Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.11.4 Sanofi (France), Zoetis (U.S.). Business Overview
3.12 INOVIO Pharmaceuticals (U.S.).
3.12.1 INOVIO Pharmaceuticals (U.S.). Company Profile
3.12.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.12.3 INOVIO Pharmaceuticals (U.S.). Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.12.4 INOVIO Pharmaceuticals (U.S.). Business Overview
3.13 General Electric (U.S.)
3.13.1 General Electric (U.S.) Company Profile
3.13.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.13.3 General Electric (U.S.) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.13.4 General Electric (U.S.) Business Overview
3.14 Biomay AG (Austria)
3.14.1 Biomay AG (Austria) Company Profile
3.14.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.14.3 Biomay AG (Austria) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.14.4 Biomay AG (Austria) Business Overview
3.15 Valneva SE (France)
3.15.1 Valneva SE (France) Company Profile
3.15.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview
3.15.3 Valneva SE (France) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)
3.15.4 Valneva SE (France) Business Overview
4 Global Deoxyribonucleic Acid (DNA) Vaccines Historical and Forecast Market Analysis by Type
4.1 Global Deoxyribonucleic Acid (DNA) Vaccines Revenue and Market Share by Type
4.2 Global Deoxyribonucleic Acid (DNA) Vaccines Revenue Market Forecast by Type (2023-2029)
5 Global Deoxyribonucleic Acid (DNA) Vaccines Historical and Forecast Market Analysis by Application
5.1 Global Deoxyribonucleic Acid (DNA) Vaccines Revenue Market Share by Application (2018-2023)
5.2 Deoxyribonucleic Acid (DNA) Vaccines Revenue Market Forecast by Application (2023-2029)
6 Global Market Growth Trends Analysis
6.1 Global Deoxyribonucleic Acid (DNA) Vaccines Market Size & Forecast (2018-2029)
6.2 Deoxyribonucleic Acid (DNA) Vaccines Growth Trends Analysis by Regions
6.2.1 Deoxyribonucleic Acid (DNA) Vaccines Market Size by Regions: 2018 VS 2023 VS 2029
6.2.2 Deoxyribonucleic Acid (DNA) Vaccines Historic Revenue Market Size by Regions (2018-2023)
6.2.3 Deoxyribonucleic Acid (DNA) Vaccines Forecasted Revenue Market Size by Regions (2023-2029)
6.2.4 North America Deoxyribonucleic Acid (DNA) Vaccines Market Size & Forecast (2018-2029)
6.2.5 Europe Deoxyribonucleic Acid (DNA) Vaccines Market Size & Forecast (2018-2029)
6.2.6 China Deoxyribonucleic Acid (DNA) Vaccines Market Size & Forecast (2018-2029)
6.2.7 Japan Deoxyribonucleic Acid (DNA) Vaccines Market Size & Forecast (2018-2029)
6.2.8 Korea Deoxyribonucleic Acid (DNA) Vaccines Market Size & Forecast (2018-2029)
6.2.9 Southeast Asia Deoxyribonucleic Acid (DNA) Vaccines Market Size & Forecast (2018-2029)
6.2.10 India Deoxyribonucleic Acid (DNA) Vaccines Market Size & Forecast (2018-2029)
6.2.11 South America Deoxyribonucleic Acid (DNA) Vaccines Market Size & Forecast (2018-2029)
6.2.12 Middle East & Africa Deoxyribonucleic Acid (DNA) Vaccines Market Size & Forecast (2018-2029)
7 North America
7.1 North America Deoxyribonucleic Acid (DNA) Vaccines Revenue by Players
7.2 North America Deoxyribonucleic Acid (DNA) Vaccines Revenue by Types
7.3 North America Deoxyribonucleic Acid (DNA) Vaccines Revenue by Applications
7.4 North America Deoxyribonucleic Acid (DNA) Vaccines Revenue, Gross and Gross Margin (2018-2023)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Deoxyribonucleic Acid (DNA) Vaccines Revenue by Players
8.2 Europe Deoxyribonucleic Acid (DNA) Vaccines Revenue by Types
8.3 Europe Deoxyribonucleic Acid (DNA) Vaccines Revenue by Applications
8.4 Europe Deoxyribonucleic Acid (DNA) Vaccines Revenue, Gross and Gross Margin (2018-2023)
8.5 Europe PEST Analysis
9 China
9.1 China Deoxyribonucleic Acid (DNA) Vaccines Revenue by Players
9.2 China Deoxyribonucleic Acid (DNA) Vaccines Revenue by Types
9.3 China Deoxyribonucleic Acid (DNA) Vaccines Revenue by Applications
9.4 China Deoxyribonucleic Acid (DNA) Vaccines Revenue, Gross and Gross Margin (2018-2023)
9.5 China PEST Analysis
10 Japan
10.1 Japan Deoxyribonucleic Acid (DNA) Vaccines Revenue by Players
10.2 Japan Deoxyribonucleic Acid (DNA) Vaccines Revenue by Types
10.3 Japan Deoxyribonucleic Acid (DNA) Vaccines Revenue by Applications
10.4 Japan Deoxyribonucleic Acid (DNA) Vaccines Revenue, Gross and Gross Margin (2018-2023)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Deoxyribonucleic Acid (DNA) Vaccines Revenue by Players
11.2 Korea Deoxyribonucleic Acid (DNA) Vaccines Revenue by Types
11.3 Korea Deoxyribonucleic Acid (DNA) Vaccines Revenue by Applications
11.4 Korea Deoxyribonucleic Acid (DNA) Vaccines Revenue, Gross and Gross Margin (2018-2023)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Deoxyribonucleic Acid (DNA) Vaccines Revenue by Players
12.2 Southeast Asia Deoxyribonucleic Acid (DNA) Vaccines Revenue by Types
12.3 Southeast Asia Deoxyribonucleic Acid (DNA) Vaccines Revenue by Applications
12.4 Southeast Asia Deoxyribonucleic Acid (DNA) Vaccines Revenue, Gross and Gross Margin (2018-2023)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Deoxyribonucleic Acid (DNA) Vaccines Revenue by Players
13.2 India Deoxyribonucleic Acid (DNA) Vaccines Revenue by Types
13.3 India Deoxyribonucleic Acid (DNA) Vaccines Revenue by Applications
13.4 India Deoxyribonucleic Acid (DNA) Vaccines Revenue, Gross and Gross Margin (2018-2023)
13.5 India PEST Analysis
14 South America
14.1 South America Deoxyribonucleic Acid (DNA) Vaccines Revenue by Players
14.2 South America Deoxyribonucleic Acid (DNA) Vaccines Revenue by Types
14.3 South America Deoxyribonucleic Acid (DNA) Vaccines Revenue by Applications
14.4 South America Deoxyribonucleic Acid (DNA) Vaccines Revenue, Gross and Gross Margin (2018-2023)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Deoxyribonucleic Acid (DNA) Vaccines Revenue by Players
15.2 Middle East & Africa Deoxyribonucleic Acid (DNA) Vaccines Revenue by Types
15.3 Middle East & Africa Deoxyribonucleic Acid (DNA) Vaccines Revenue by Applications
15.4 Middle East & Africa Deoxyribonucleic Acid (DNA) Vaccines Revenue, Gross and Gross Margin (2018-2023)
15.5 Middle East & Africa PEST Analysis
16 Deoxyribonucleic Acid (DNA) Vaccines Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Deoxyribonucleic Acid (DNA) Vaccines Industrial Chain Analysis
17 Deoxyribonucleic Acid (DNA) Vaccines Industry Dynamic Analysis
17.1 Deoxyribonucleic Acid (DNA) Vaccines Market Trends Analysis
17.2 Deoxyribonucleic Acid (DNA) Vaccines Market Drivers Analysis
17.3 Deoxyribonucleic Acid (DNA) Vaccines Market Challenges Analysis
17.4 Deoxyribonucleic Acid (DNA) Vaccines Market Restraints Analysis
18 Research Findings and Conclusion

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Deoxyribonucleic Acid (DNA) Vaccines Professional Market Insights, Players, Region, Type & Application Analysis 2018-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?